RichelleCandiceCharlesMD

Infectious Disease • Boston, MA

Instructor in Medicine, Massachusetts General Hospital

Join to view full profile

Dr. Charles is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Charles' full profile

Already have an account?

Office
55 Fruit St
Massachusetts General Hospital Wac 645 7
Boston, MA 02114
Phone+1 617-726-2066

Fax+1 617-726-2894

Education & Training

Massachusetts General Hospital/Brigham and Women's Hospital/Harvard Medical SchoolFellowship, Infectious Disease, 2006 - 2008
Massachusetts General HospitalResidency, Internal Medicine, 2003 - 2006
Johns Hopkins University School of MedicineClass of 2003

Certifications & Licensure

MA State Medical License 2005 - 2025
American Board of Internal Medicine Internal Medicine
American Board of Internal Medicine Infectious Disease

Publications & Presentations

PubMed

1 citations
Development of a Shigella conjugate vaccine targeting Shigella flexneri 6 that is immunogenic and provides protection against virulent challenge.
Meagan Kelly, Jeshina Janardhanan, Chanchal Wagh, Smriti Verma, Richelle C Charles
Vaccine. 2024-10-24
Evaluation of a point-of-care multiplex immunochromatographic assay for the diagnosis of typhoid: results from a retrospective diagnostic accuracy study.
Rumina Hasan, Zahida Azizullah, Hina Shams, Sabine Dittrich, Jason R Andrews
Journal of Clinical Microbiology. 2024-10-16
2 citations
Determinants of immune responses predictive of protection against shigellosis in an endemic zone: a systems analysis of antibody profiles and function.
Biana Bernshtein, Meagan Kelly, Deniz Cizmeci, Julia A Zhiteneva, Ryan Macvicar
The Lancet. Microbe. 2024-10-01

Journal Articles

Defining Endemic Cholera at Three Levels of Spatiotemporal Resolution Within Bangladesh
Richelle C Charles, Stephen B Calderwood, Jason B Harris, Regina C LaRocque, Edward T Ryan, Nature

Press Mentions

Here’s Why Omicron Is “Milder” but Still Wreaking Havoc on HealthcareJanuary 13th, 2022
New Reports Show Coronavirus Immunity Can Last for MonthsOctober 15th, 2020
Multiple New Studies Say COVID-19 Antibodies Last Several MonthsOctober 14th, 2020
Join now to see all

Grant Support

High-Throughput Proteomic Study Of Protective Immunity In Human Cholera InfectionNational Institute Of Allergy And Infectious Diseases2010–2012